Medplus Health Services Ltd.
NSE: MEDPLUS | BSE: 543427
₹870.70
₹-11.25
(-1.28%)
As on 15-Jun-2026 15:57IST
Market cap
₹10,486 Cr
Revenue (TTM)
₹6,892 Cr
P/E Ratio
47.7
P/B Ratio
5.3
Div. Yield
0 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
4/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹220 Cr
-
ROE
9.2 %
-
ROCE
18.2 %
-
Industry P/E
36.31
-
EV/EBITDA
14.8
-
Debt to Equity
0
-
Book Value
₹164.4
-
EPS
₹18.3
-
Face value
2
-
Shares outstanding
120,137,061
10 Years Aggregate
CFO
₹1,071.74 Cr
EBITDA
₹2,041.36 Cr
Net Profit
₹526.68 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Medplus Health
| 7.9 | -2.8 | 2.5 | -1.1 | 4.1 | -- | -- |
|
BSE Healthcare
| 8.6 | 0.1 | 10.2 | 7.2 | 24.4 | 13.1 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
Medplus Health
| -4.9 | 12.2 | 22.4 | -40.8 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Medplus Health
|
870.7 | 10,486.2 | 6,892.5 | 219.6 | 4.7 | 11.5 | 47.7 | 5.3 |
| 77.0 | 28.6 | 53.8 | -2.2 | 2.0 | -7.5 | -- | 1.1 | |
| 64.4 | 32.6 | 149.1 | 3.1 | 3.4 | 2.8 | 26.8 | 0.6 | |
| 2,213.1 | 36,593.8 | 6,430.7 | 1,027.3 | 18.8 | 10.5 | 35.6 | 3.5 | |
| 226.8 | 1,257.3 | 277.9 | 26.4 | 9.9 | 8.3 | 43.4 | 5.2 | |
| 20.0 | 11.0 | 7.9 | 0.7 | 12.2 | 46.1 | 14.9 | 6.1 | |
| 1,510.9 | 15,358.0 | 1,875.3 | 315.1 | 17.4 | 10.9 | 47.7 | 4.9 | |
| 141.5 | 53.2 | 21.6 | 3.2 | 20.8 | 18.6 | 16.9 | 3.0 |
Shareholding Pattern
View DetailsNews & Analysis
All News
MedPlus Health Services IPO: How good is it?
5 min read•By Danish Khanna
About Medplus Health
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness products, such as prescription medicines, over-the-counter drugs, vitamins, medical... devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India. Read more
-
Incorporated
2006
-
Chairman
Gangadi Madhukar Reddy
-
Managing Director
Gangadi Madhukar Reddy
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about Medplus Health Services Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Medplus Health
What is the current share price of Medplus Health Services Ltd Today?
The share price of Medplus Health Services Ltd is ₹870.70 (NSE) and ₹870.60 (BSE) as of 15-Jun-2026 15:57 IST. Medplus Health Services Ltd has given a return of 4.12% in the last 3 years.
What is the current PB & PE ratio of Medplus Health Services Ltd?
The P/E ratio of Medplus Health Services Ltd is 47.74 times as on 15-Jun-2026, a 31 premium to its peers’ median range of 36.31 times.
The P/B ratio of Medplus Health Services Ltd is 5.31 times as on 15-Jun-2026, a 48 premium to its peers’ median range of 3.60 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
60.48
|
5.30
|
|
2024
|
125.87
|
5.33
|
|
2023
|
156.11
|
5.32
|
|
2022
|
125.80
|
8.57
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Medplus Health Services Ltd?
The 52-week high and low of Medplus Health Services Ltd are Rs 1,022.20 and Rs 732.00 as of 15-Jun-2026.
What is the market cap of Medplus Health Services Ltd?
Medplus Health Services Ltd has a market capitalisation of ₹ 10,486 Cr as on 15-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Medplus Health Services Ltd?
Before investing in Medplus Health Services Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.